Impact of Smoking Cessation Attempts on Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Large Propensity Score–Matched Cohort Study
Canadian Journal of Gastroenterology and Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/cjgh/5902236 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, online erschienen am 29.04.2026. Verfasst von Mohammad Alabbas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA, clevelandclinic.org. Hauptthemen laut MEDLINE: Smoking Cessation, Fatty Liver. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Metabolic dysfunction–associated steatotic liver disease (MASLD) is highly prevalent, and smoking is associated with greater disease severity. We investigated whether documented smoking cessation attempts among adults with MASLD were associated with liver‐related outcomes, cardiovascular outcomes, and all‐cause mortality.
Methods
We performed a retrospective cohort study using the TriNetX Research Network. Adults (≥ 18 years) with MASLD and documented smoking history were included. A smoking cessation attempt was defined by cessation counseling and/or cessation pharmacotherapy; comparators had no documented cessation attempt. Patients with depressive disorders and competing liver etiologies were excluded. Cohorts were matched 1:1 using propensity scores, and outcomes were analyzed using Cox proportional hazards models. Sensitivity analyses were performed at fixed follow‐up horizons of 6 months, 1 year, and 2 years.
Results
Among 418,784 eligible patients, 85,639 had a documented cessation attempt and 333,145 did not; after matching, 83,315 patients remained in each cohort. In the matched cohort, cessation attempt was associated with lower hazards of cirrhosis progression (1.7% vs. 2.1%; HR 0.87, 95% CI 0.81–0.93), hepatocellular carcinoma (0.2% vs. 0.3%; HR 0.58, 95% CI 0.48–0.70), portal hypertension (0.8% vs. 1.1%; HR 0.77, 95% CI 0.70–0.86), and MASH progression (2.2% vs. 2.9%; HR 0.76, 95% CI 0.71–0.81). The cessation attempt was also associated with higher hazards of MACE (13.6% vs. 11.4%; HR 1.24, 95% CI 1.20–1.28), peripheral artery disease (4.1% vs. 3.2%; HR 1.33, 95% CI 1.26–1.40), and all‐cause mortality (8.5% vs. 7.3%; HR 1.23, 95% CI 1.18–1.27). Fixed‐horizon analyses showed similar patterns over time.
Conclusions
In adults with MASLD and smoking history, documented smoking cessation attempts were associated with lower hazards of several liver outcomes but higher cardiovascular event rates and mortality, findings likely influenced by residual confounding and clinical risk clustering in patients receiving cessation interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA, clevelandclinic.org.
- Division of Gastroenterology and Hepatology, NewYork-Presbyterian Hospital/Weill Cornell Medicine, New York, New York, USA, utsouthwestern.edu.
- Division of Digestive and Liver Disease, University of Texas Southwestern Medical Center, Dallas, Texas, USA, utsouthwestern.edu.
- Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary, unideb.hu.
- Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA, clevelandclinic.org.
- Department of Gastroenterology and Hepatology, Charleston Area Medical Center, Charleston, West Virginia, USA, camc.org.
ORCID-Profile: Mohammad Alabbas, Barbara Balog, Omar T Sims
Zitieren
APA
Alabbas, M., Hamid, O., Balog, B., Bhagat, U., Saab, O., Nanah, R., Sims, O. T., & Esfeh, J. M. (2026). Impact of Smoking Cessation Attempts on Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Large Propensity Score–Matched Cohort Study. Canadian Journal of Gastroenterology and Hepatology, 2026(1). https://doi.org/10.1155/cjgh/5902236
Vancouver
Alabbas M, Hamid O, Balog B, Bhagat U, Saab O, Nanah R, et al. Impact of Smoking Cessation Attempts on Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Large Propensity Score–Matched Cohort Study. Canadian Journal of Gastroenterology and Hepatology. 2026;2026(1). doi:10.1155/cjgh/5902236
BibTeX
@article{Alabbas2026,
author = {Alabbas, Mohammad and Hamid, Osama and Balog, Barbara and Bhagat, Umesh and Saab, Omar and Nanah, Rama and Sims, Omar T and Esfeh, Jamak Modaresi},
title = {Impact of Smoking Cessation Attempts on Outcomes in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Large Propensity Score–Matched Cohort Study},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cjgh/5902236}
}
EUVIMED